EDIT vs NTLA
EDIT 与 NTLA 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | EDITEDITAS MEDICINE, INC. | NTLAINTELLIA THERAPEUTICS, INC. |
|---|---|---|
| 市值 | $409.29M | $1.75B |
| 市销率 | 10.1x | 25.8x |
| 营收同比增长 | 25.4% | 16.9% |
| 净利同比增长 | 32.5% | 20.5% |
| 息税前利润率 | -394.9% | -651.7% |
| 净资产收益率 | -152.0% | -56.7% |
| 一年总回报 | -11.2% | +1.6% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:EDIT vs NTLA
| 指标 | EDIT | NTLA |
|---|---|---|
| 期末价值 | $1.1K | $5.5K |
| 总回报 | -89.4% | -45.1% |
| 年化收益 (CAGR) | -19.5% | -5.6% |
| 波动率 | 83.6% | 78.3% |
| 夏普比率 | 0.09 | 0.26 |
| 索提诺比率 | 0.14 | 0.39 |
| 最大回撤 | -98.9% | -96.5% |
基于 2600 个共同交易日,2016-06-29 → 2026-10-30 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)